Chemerin induced expression of inflammatory and degradative mediators in these cells, including IL-6, CCL2, and MMP-3 in RASF, CCL2, and TLR4 in SF from RA and OA patients, and IL-1β in chondrocytes. The gene discussed is CCL2; the disease is rheumatoid arthritis.